4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염

4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염
4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염 구조식 이미지
카스 번호:
144734-36-1
한글명:
4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염
동의어(한글):
4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염
상품명:
4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)PIPERIDINE OXALATE
동의어(영문):
4F 4PP OXALATE;4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)PIPERIDINE OXALATE;(4-Fluorophenyl)(1-(4-phenylbutyl)piperidin-4-yl)methanone oxalate;selective,potentials,Inhibitor,Serotonin Receptor,4F 4PP,ketanserin,5-HT Receptor,inhibit,4F 4PP oxalate,5-HT2C,5-hydroxytryptamine Receptor,DAMGO
CBNumber:
CB2340720
분자식:
C24H28FNO5
포뮬러 무게:
429.48
MOL 파일:
Mol file

4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염 속성

저장 조건
Store at RT
용해도
Soluble to 100 mM in DMSO and to 20 mM in ethanol
물리적 상태
가루
색상
White to off-white

안전

4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염 C화학적 특성, 용도, 생산

용도

4F 4PP oxalate is a selective SR-2A antagonist.

생물학적 활성

A selective 5-HT 2A antagonist with almost as high affinity (K i = 5.3 nM) as ketanserin but with a much lower affinity for 5-HT 2C sites (K i = 620 nM).

4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염 준비 용품 및 원자재

원자재

준비 용품


4-(4-플루오로벤조일)-1-(4-페닐부틸)피페리딘옥살산염 공급 업체

글로벌( 28)공급 업체
공급자 전화 이메일 국가 제품 수 이점
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32165 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57505 58
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037
3bsc@sina.com China 15839 69
EMMX Biotechnology LLC 888-539-0666
info@emmx.com United States 8447 60
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9806 58
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720
klq@cw-bio.com China 4600 55
BOC Sciences --
info@bocsci.com USA 0 65
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44808 58
Jinan Jiuli Biotechnology Co. , Ltd. 15865264761
486064515@qq.com China 3732 58
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62075 58

Copyright 2019 © ChemicalBook. All rights reserved